SABIC posts SAR 4.8B loss in 9M 2025, earns SAR 440M in Q3 9 M 2025 SABIC loses SAR 5.28B in H1 2025, SAR 4.1B in Q2 on one-off provisions 6 M 2025 SABIC swings to net loss of SAR 1.21B in Q1 2025 3 M ...
A research group at the Universidade Federal do Rio de Janeiro has advanced polylaminin, a laminin-based biomaterial, from preclinical investigation to early human testing in spinal cord injury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results